Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Rau

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Zeitschrift Fur Rheumatologie|January 12, 2022
[The 32nd emeriti meeting in Düsseldorf 9-12 September 2021]Rolf Rau, Hans-Hartmut Peter
Zeitschrift Fur Rheumatologie|December 12, 2023
Gertraud Herborn, Rolf Rau, Siegfried Wassenberg
Zeitschrift Fur Rheumatologie|August 26, 2016
[Gold as an alternative in the treatment of RA patients with malignancies]Oliver Sander, Rolf Rau, Matthias Schneider
Arthritis and Rheumatism|October 31, 2007
Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass indexGisela Westhoff, Rolf Rau, Angela Zink
Arthritis and Rheumatism|October 29, 2005
Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trialSiegfried Wassenberg, Rolf Rau, Paul Steinfeld, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritisDietmar Krause, Bernadette Gabriel, Gertraud Herborn, et al.
Clinical Rheumatology|February 28, 2016
Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritisDietmar Krause, Bernadette Gabriel, Gertraud Herborn, et al.
Clinical Rheumatology|August 9, 2013
Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugsChristoph Fiehn, Elisabeth Belke-Voss, Dietmar Krause, et al.
The Journal of Rheumatology|May 8, 2003
OMERACT workshop: repair of structural damage in rheumatoid arthritisDésirée Van Der Heijde, John T Sharp, Rolf Rau, et al.
Clinical and Experimental Rheumatology|December 16, 2016
Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baselineCarolin Krause, Gertraud Herborn, Juergen Braun, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Zeitschrift Fur Rheumatologie|January 12, 2022
[The 32nd emeriti meeting in Düsseldorf 9-12 September 2021]Rolf Rau, Hans-Hartmut Peter
Zeitschrift Fur Rheumatologie|December 12, 2023
Gertraud Herborn, Rolf Rau, Siegfried Wassenberg
Zeitschrift Fur Rheumatologie|August 26, 2016
[Gold as an alternative in the treatment of RA patients with malignancies]Oliver Sander, Rolf Rau, Matthias Schneider
Arthritis and Rheumatism|October 31, 2007
Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass indexGisela Westhoff, Rolf Rau, Angela Zink
Arthritis and Rheumatism|October 29, 2005
Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trialSiegfried Wassenberg, Rolf Rau, Paul Steinfeld, et al.
Clinical and Experimental Rheumatology|August 29, 2015
Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritisDietmar Krause, Bernadette Gabriel, Gertraud Herborn, et al.
Clinical Rheumatology|February 28, 2016
Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritisDietmar Krause, Bernadette Gabriel, Gertraud Herborn, et al.
Clinical Rheumatology|August 9, 2013
Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugsChristoph Fiehn, Elisabeth Belke-Voss, Dietmar Krause, et al.
The Journal of Rheumatology|May 8, 2003
OMERACT workshop: repair of structural damage in rheumatoid arthritisDésirée Van Der Heijde, John T Sharp, Rolf Rau, et al.
Clinical and Experimental Rheumatology|December 16, 2016
Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baselineCarolin Krause, Gertraud Herborn, Juergen Braun, et al.
Pageof 5